文献速递慢性静脉疾病

踝下静脉性溃疡经Unna靴治疗可愈合

Inframalleolar venous ulcers heal with Unna boot therapy.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2026-06-02

>90%愈合率为51.8%,单纯静脉性溃疡愈合优于混合性(P = .01),足跟溃疡复发率更高(P = .002)。

要点

  • 踝下静脉性溃疡经Unna靴加压治疗可获得显著治疗获益。
  • 单纯静脉性溃疡较混合性溃疡更易愈合(P = .01)。
  • 足跟溃疡愈合不差但复发率更高(P = .002)。

核心结论

  • Unna靴加压治疗对踝下静脉性溃疡患者具有显著治疗获益,且易于获得、成本效益好。

研究设计与样本

  • 回顾性单中心研究,纳入2012年5月至2023年5月治疗的71例踝下静脉性溃疡患者,其中12例双侧溃疡,共83条患肢。

主要发现

  • >90%愈合成功率为51.8%。
  • 单纯静脉性溃疡愈合优于混合性溃疡(P = .01)。
  • 足跟溃疡与其他部位相比愈合无劣势(P = .10),但复发率更高(P = .002)。
  • 26.76%患者溃疡复发,45.13%未复发,8.4%仍在治疗中,19.71%失访。
  • 同肢合并踝上溃疡与踝下溃疡愈合改善显著相关(P = .02)。

关键数值与推荐

  • 所有患者均有双下肢肿胀及静脉反流>500 ms提示静脉功能不全。
  • 初始纳入需可触及足背动脉且踝肱指数(ABI)正常,后放宽至混合性动静脉疾病且ABI>0.6。
  • 孤立动脉病变且ABI<0.6及糖尿病神经性溃疡病因者排除。
  • 每周Unna靴治疗,平均治疗时长12 ± 23周(范围1-181周),中位5周;愈合后平均随访16 ± 28个月。

临床怎么用

  • 踝下静脉性溃疡可采用Unna靴加压治疗,尤其单纯静脉性溃疡患者。
  • 足跟溃疡愈合后需关注更高复发风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study highlights the presentation of inframalleolar ulcers in venous disease, their wound healing factors, recurrence rate, and response to Unna boot treatment with adjunct endovenous and/or iliac vein stenting treatments. METHODS: This retrospective single-center study included 71 office-based patients with inframalleolar venous ulcers treated between May 2012 and May 2023. Of the 71 patients evaluated, 12 presented with bilateral ulcers, resulting in a total of 83 limbs treated. Patient demographics including age, sex, ulcer etiology, ulcer location, diabetes status, and treatment modality were evaluated. All patients presented with bilateral leg swelling and venous reflux greater than 500 ms suggestive of venous insufficiency. Initially, patients were required to have palpable pedal pulses and a normal ankle-brachial index (ABI) for inclusion. Over time, inclusion criteria were broadened to accept patients with mixed arterial venous disease, provided their ABI was greater than 0.6. Patients with isolated arterial pathology and an ABI <0.6 and those with diabetic neuropathic ulcer etiology were excluded from this study. Patients received compression therapy that included an elastic all-cotton elastic wrap and an inelastic Unna boot formulated with calamine, zinc oxide, and glycerin, both applied by trained medical assistants. Sixty-five patients received additional endovenous and/or iliac vein stenting treatments. RESULTS: The mean patient age was 67 ± 14 years (range, 25-96 years). Of the 71 patients treated, 12 (16.9%) presented with ulcers on both limbs, resulting in a total of 83 limbs treated. All ulcers were treated with weekly Unna boots, with an average treatment duration of 12 ± 23 weeks (range, 1-181 weeks) and a median treatment duration of 5 weeks. After wound healing, patients were followed for a mean duration of 16 ± 28 months. The success rate of >90% healing for inframalleolar ulcers was 51.8%. Factors associated with wound healing were ulcers that were primarily venous in nature as opposed to mixed (P = .01). Heel ulcers were not associated with inferior wound healing (P = .10) compared with other locations but were associated with higher rates of recurrence (P = .002). In total, 26.76% of patients had recurrent ulcers, whereas 45.13% did not; 8.4% of ulcers were still actively being treated with Unna boots, and 19.71% of patients were lost to follow-up. Improved healing of inframalleolar ulcers was significantly associated with the presence of a concomitant supramalleolar ulcer on the same limb (P = .02). CONCLUSIONS: This study brings attention to the uncommon presentation of inframalleolar ulcers in venous stasis disease and is driven by the observation that bilateral leg swelling can lead to poor wound healing. Compression therapy using Unna boots is easily accessible, cost-effective, and should be considered as it offers significant therapeutic benefit in this patient population.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Karren CL, Gill-Jones NDS, Robbins JM, et al. Inframalleolar venous ulcers heal with Unna boot therapy. J Vasc Surg Venous Lymphat Disord. 2026. PMID: 42235637. doi:10.1016/j.jvsv.2026.102549

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。